Induction and concurrent chemoradiotherapy for non-small cell lung cancer (NSCLC) using cisplatin and vinorelbine

被引：0
|
作者：
Ho, G. Fuang [1 ]
Popat, S. [2 ]
Nutting, C. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Clin Oncol, London SW3 6JJ, England
[2] Royal Marsden Hosp, Dept Med Oncol, London SW3 6JJ, England
来源：
LUNG CANCER | 2008年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
55
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [41] Vinorelbine for non-small cell lung cancer
    Piccirillo, Maria Carmela
    Daniele, Gennaro
    Di Maio, Massimo
    Bryce, Jane
    De Feo, Gianfranco
    Del Giudice, Antonia
    Perrone, Francesco
    Morabito, Alessandro
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (03) : 493 - 510
  • [42] Induction chemotherapy followed by concurrent chemoradiotherapy (CRT) and surgery in locally advanced non-small cell lung carcinoma (NSCLC)
    Costa, MA
    Zukin, M
    Pinel, MI
    Roriz, W
    Zamboni, MM
    Cunha, ET
    Cordeiro, PB
    Torquato, E
    Goncalves, MCC
    Campos, L
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 95
  • [43] Real-World Data Comparing Cisplatin/Vinorelbine and Carboplatin/Paclitaxel in Concurrent Chemoradiation for Non-Small Cell Lung Cancer (NSCLC): Safety and Outcomes
    Chan, Christopher Wei En
    Abdelaziz, Noha
    Makady, Nafie Faisal
    LUNG CANCER, 2025, 200
  • [44] Induction chemotherapy followed by concurrent chemoradiotherapy and operation in locally advanced non-small cell lung cancer
    Jeremic, B
    Zimmermann, FB
    Molls, M
    ANNALS OF THORACIC SURGERY, 2003, 76 (03): : 979 - 979
  • [45] Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer
    Tan, EH
    Wee, J
    Ang, PT
    Fong, KW
    Leong, SS
    Khoo, KS
    Tan, T
    Lee, KS
    Eng, P
    Hsu, A
    Tan, YK
    Chua, EJ
    Ong, YY
    ACTA ONCOLOGICA, 1999, 38 (08) : 1005 - 1009
  • [46] Preoperative Concurrent Chemoradiotherapy of S-1/Cisplatin for Stage III Non-Small Cell Lung Cancer
    Yamaguchi, Masafumi
    Toyokawa, Gouji
    Ohba, Taro
    Sasaki, Tomonari
    Kometani, Takuro
    Hamatake, Motoharu
    Hirai, Fumihiko
    Taguchi, Kenichi
    Yamanaka, Takeharu
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Sugio, Kenji
    Ichinose, Yukito
    ANNALS OF THORACIC SURGERY, 2013, 96 (05): : 1783 - 1789
  • [47] Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).
    Zhang, Y
    Zhang, L
    Li, N
    Xu, F
    Pan, ZK
    Guang, ZZ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [48] Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer
    Katsui, Kuniaki
    Ogata, Takeshi
    Watanabe, Kenta
    Yoshio, Kotaro
    Kuroda, Masahiro
    Hiraki, Takao
    Kiura, Katsuyuki
    Maeda, Yoshinobu
    Toyooka, Shinichi
    Kanazawa, Susumu
    ACTA MEDICA OKAYAMA, 2021, 75 (03) : 269 - 277
  • [49] Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): A feasibility study
    Beckmann, G
    Fietkau, R
    Huber, RM
    Kleine, P
    Schmidt, M
    Semrau, S
    Aubert, D
    Fittipaldo, A
    Flentje, M
    ONKOLOGIE, 2006, 29 (04): : 137 - 142
  • [50] Vinorelbine (VNR) and concurrent thoracic radiation therapy (TRT) in locally advanced non-small cell lung cancer (NSCLC)
    Portalone, L. I.
    Lombardi, A.
    Luca, F.
    Signora, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345